» Authors » S Shirolkar

S Shirolkar

Explore the profile of S Shirolkar including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 12
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Schoenwald R, BARFKNECHT C, Shirolkar S, Xia E
Life Sci . 1995 Mar; 56(15):1275-85. PMID: 8614245
Sigma receptor antagonists have been proposed as leading clinical candidates for use in various psychotic disorders. Prior to clinical testing, it is imperative that a new agent be correctly identified...
2.
Shirolkar S, Schoenwald R, BARFKNECHT C, Yang Y, Vidvauns S
J Ocul Pharmacol Ther . 1995 Jan; 11(1):41-7. PMID: 8535956
In an effort to develop a long-term topically active tear stimulant, it was important to determine if tolerance developed following the repeated instillation of N,N-Dimethyl-2-phenylethylamine hydrochloride (AF2975) to the albino...
3.
Schoenwald R, BARFKNECHT C, Shirolkar S, Xia E, Ignace C
Adv Exp Med Biol . 1994 Jan; 350:141-6. PMID: 8030466
No abstract available.
4.
Shirolkar S, Schoenwald R, BARFKNECHT C, Xia E, Cheng B, Iwai Y, et al.
J Ocul Pharmacol . 1993 Jan; 9(3):211-27. PMID: 8228530
3H-DTG (1.3-di(2-[5-3H]tolyl)guanidine) or 3H-haloperidol was added to sigma-receptors (25 nM) in the presence of 25 nM spiperone and incubated with increasing concentrations of bromhexine derivatives (phenylalkylamines; 10(-9) to 10(-2)M) in...
5.
Deshpande S, Shirolkar S
J Pharm Pharmacol . 1989 Mar; 41(3):197-200. PMID: 2568450
The bioavailability of drugs from conventional ophthalmic formulations is low. To optimize the therapy, sustained release ophthalmic dosage forms are warranted. Hydrogels such as sodium-carboxymethyl cellulose, hydroxypropylmethyl cellulose, Carbopol-940, Carbopol-941...